Fierce Biotech5d
Amgen ignites Rocket program with phase 3 wins for $400M eczema prospect
Amgen’s $400 million eczema drug candidate has recorded two more phase 3 victories. The data drops provide more evidence that ...
SpaceX’s Starship: The most powerful rocket ever built is poised for its first flight since explosive mishap
Starship, the most powerful launch system ever built, is set to take off on its eighth test flight about six weeks after an ...
TweakTown4d
SpaceX release Starship launch footage from an angle I didn't think was possible
SpaceX has released footage of the most recent Starship launch from an angle I didn't think was possible, showcasing the ...
BioSpace4d
Amgen, Kyowa Kirin’s Rocatinlimab Picks Up Steam With Late-Stage Atopic Dermatitis Win
In September 2024, a readout from a separate trial of rocatinlimab elicited mixed reactions from analysts, who found the ...
Florida Keys Weekly Newspapers2d
‘RAPID UNSCHEDULED DISASSEMBLY’: SPACEX STARSHIP EXPLODES IN SKIES NEAR FLORIDA KEYS
On March 6, dozens of videos of the fiery skies over Marathon spread like wildfire on social media when a test flight of ...
Morningstar7d
AMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Results from IGNITE, SHUTTLE and VOYAGER will be presented at upcoming congresses or published in peer-reviewed journals. About the ROCKET Phase 3 Program ROCKET is a comprehensive, global Phase 3 ...
Amgen, Kyowa announces new results from ongoing ROCKET Phase 3 study
Amgen (AMGN) and Kyowa Kirin (KYKOF) announced new results from the ongoing ROCKET Phase 3 clinical trial program evaluating rocatinlimab, an ...
Pharmabiz4d
Amgen & Kyowa Kirin positive results from rocatinlimab phase 3 IGNITE study in adults with moderate to severe atopic dermatitis
Amgen & Kyowa Kirin positive results from rocatinlimab phase 3 IGNITE study in adults with moderate to severe atopic dermatitis: Thousand Oaks, California Tuesday, March 11, 2025, ...